Neuro-Oncology Department, Cancer Center
Beijing Tiantan Hospital, Capital Medical University, Beijing, China

 

Dr. Wenbin Li mainly engaged in the comprehensive treatment of brain tumors, and presided over 30 new drug clinical trials in brain tumors as the PI.  He is the coordinator of the China Center for the "GBM Adaptive Global Innovative Learning Environment". He engaged in the translational research of brain tumors, and has published more than 100 articles in international and Chinese peer-reviewed journals with the highest impact factor of 38.01.

He is the Appointed Chairman of China Pharmaceutical Industry Research Development Association, Head of the National Key Clinical Specialty, and member of the Academic Committee of Asian Oncology Society.